articleTop 1% cited
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder
Urology · 2001 · Vol. 57(3) · pp. 414–421
Philip Van Kerrebroeck✉(Maastricht University Medical Centre)Karl J. Kreder(University of Iowa Hospitals and Clinics)Udo Jonas(Medizinische Hochschule Hannover)N. ZinnerAlan J. Wein(University of Pennsylvania Health System)
Urinary Bladder and Prostate ResearchUrinary Tract Infections ManagementPelvic floor disorders treatmentsTolterodineTolerabilityMedicinePlaceboUrinationOveractive bladderUrologyUrinary incontinenceAdverse effectAnesthesia
MeSH terms
Tolterodine TartrateAdministration, OralAdultBenzhydryl CompoundsUrinary Bladder DiseasesCresolsDouble-Blind MethodDrug Administration ScheduleFemaleHumansMalePhenylpropanolamineUrinary IncontinenceUrination DisordersMuscarinic Antagonists
Citations
459
FWCI
36.34
field-weighted impact
References
24
Percentile
100%
vs. same field & year
Citations per year
Cited by
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline
The Journal of Urology · 2012 · 699 citations
The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis
European Urology · 2008 · 763 citations
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder
British Journal of Pharmacology · 2006 · 629 citations
References
Explicit criteria for determining potentially inappropriate medication use by the elderly. An update
Archives of Internal Medicine · 1997 · 1,249 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.